Allogeneic Hematopoietic Stem Cell Transplantions in Blastic Plasmacytoid Dendritic Cell Neoplasm in first complete remission: an effective therapy for a rare disease.

The article presents the study that investigates the effectiveness of allogeneic hematopoietic stem cell transplantation in the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in Canada. The topics discussed include the symptoms associated with the BPDCN, the results of the randomized controlled trial that evaluates the efficacy of acute lymphoblastic leukemia (ALL) in treating BPDCN, and the patients overall survival.